1 – 20 of 21
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Secular trends of sustained remission in rheumatoid arthritis, a nationwide study in Sweden
(
- Contribution to journal › Article
- 2018
-
Mark
Antibody response to 13-valent pneumococcal conjugate vaccine is not impaired in patients with rheumatoid arthritis or primary Sjögren’s syndrome without disease modifying treatment
(
- Contribution to journal › Article
- 2017
-
Mark
Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine
(
- Contribution to journal › Article
-
Mark
Rituximab in clinical practice : dosage, drug adherence, Ig levels, infections, and drug antibodies
(
- Contribution to journal › Article
- 2013
-
Mark
Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis
(
- Contribution to journal › Article
- 2007
-
Mark
Development of draft validation criteria for a soluble biomarker to be regarded as a valid biomarker reflecting structural damage endpoints in rheumatoid arthritis and spondyloarthritis clinical trials
(
- Contribution to journal › Article
-
Mark
Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
(
- Contribution to journal › Article
- 2006
-
Mark
Influence of methotrexate, TNF blockers and prednisolone on antibody responses to pneumococcal polysaccharide vaccine in patients with rheumatoid arthritis.
(
- Contribution to journal › Article
- 2005
-
Mark
Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis
(
- Contribution to journal › Article
- 2004
-
Mark
Hormone replacement therapy, calcium and vitamin D-3 versus calcium and vitamin D-3 alone decreases markers of cartilage and bone metabolism in rheumatoid arthritis: a randomized controlled trial [ISRCTN46523456]
(
- Contribution to journal › Article
- 2000
-
Mark
Molecular markers for assessment of cartilage damage in rheumatoid arthritis
2000) p.291-304(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1999
-
Mark
Lower disease activity and disability in Swedish patients with rheumatoid arthritis in 1995 compared with 1978
(
- Contribution to journal › Article
- 1997
-
Mark
Serum analyses of tissue derived macromolecules and markers of inflammation in early rheumatoid arthritis. Relation to development of joint destructions in hands and feet
(
- Contribution to journal › Article
- 1996
-
Mark
Pristance-induced arthritis in rats: a new model for rheumatoid arthritis with a chronic disease course influenced by MHC and non-MHC genes
(
- Contribution to journal › Article
- 1995
-
Mark
Increased release of bone sialoprotein into synovial fluid reflects tissue destruction in rheumatoid arthritis
(
- Contribution to journal › Article
- 1992
-
Mark
Markers of cartilage destruction. In Rheumatoid Arthritis. Recent Research Advances
1992) p.348-362(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 1989
-
Mark
Involvement of nonarticular cartilage, as demonstrated by release of a cartilage-specific protein, in rheumatoid arthritis.
(
- Contribution to journal › Article
- 1988
-
Mark
Radiographic assessment in relation to clinical and biochemical variables in rheumatoid arthritis.
(
- Contribution to journal › Article
- 1987
-
Mark
Proteoglycan concentration in synovial fluid: predictor of future cartilage destruction in rheumatoid arthritis?
(
- Contribution to journal › Article
- 1985
-
Mark
Difference in cartilage proteoglycan level in synovial fluid in early rheumatoid arthritis and reactive arthritis.
(
- Contribution to journal › Article